NANOVIRICIDES, INC. — Net Income by Fiscal Year
20 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9247e3ba-5b21-4a08-ad4a-bd60050ec0df/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-9.5M | 2024-07-01 – 2025-06-30 | evidence 0001104659-25-094527 |
| FY 2024 | $-8.3M | 2023-07-01 – 2024-06-30 | evidence 0001410578-24-001650 |
| FY 2023 | $-8.6M | 2022-07-01 – 2023-06-30 | evidence 0001410578-23-002146 |
| FY 2022 | $-8.1M | 2021-07-01 – 2022-06-30 | evidence 0001410578-22-002878 |
| FY 2021 | $-8.8M | 2020-07-01 – 2021-06-30 | evidence 0001104659-21-125343 |
| FY 2020 | $-13.4M | 2019-07-01 – 2020-06-30 | evidence 0001104659-20-114577 |
| FY 2019 | $-8.4M | 2018-07-01 – 2019-06-30 | evidence 0001144204-19-041547 |
| FY 2018 | $-8.6M | 2017-07-01 – 2018-06-30 | evidence 0001144204-18-053665 |
| FY 2017 | $-10.3M | 2016-07-01 – 2017-06-30 | evidence 0001144204-17-050412 |
| FY 2016 | $-10.7M | 2015-07-01 – 2016-06-30 | evidence 0001144204-16-124276 |
| FY 2015 | $-2.2M | 2014-07-01 – 2015-06-30 | evidence 0001144204-15-054864 |
| FY 2014 | $-13.6M | 2013-07-01 – 2014-06-30 | evidence 0001144204-15-011466 |
| FY 2013 | $-46.6M | 2005-05-12 – 2014-03-31 | evidence 0001144204-14-031119 |
| FY 2012 | $-36.1M | 2005-05-12 – 2013-03-31 | evidence 0001144204-13-030526 |
| FY 2011 | $-27.8M | 2005-05-12 – 2012-03-31 | evidence 0001144204-12-030837 |
| FY 2010 | $-4.7M | 2009-07-01 – 2010-06-30 | evidence 0001144204-11-069272 |
| FY 2009 | $-2.8M | 2008-07-01 – 2009-06-30 | evidence 0001144204-11-069272 |
| FY 2008 | $-2.7M | 2007-07-01 – 2008-06-30 | evidence 0001144204-11-069272 |
| FY 2007 | $-3.1M | 2006-06-30 – 2007-06-30 | evidence 0001144204-13-054370 |
| FY 2006 | $-3.3M | 2005-06-30 – 2006-06-30 | evidence 0001144204-13-054370 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NANOVIRICIDES, INC. — all facts · Revenue · Operating Income